The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

Clinical trial NCT02622659 · COMPLETED

Trial details

NCT number: NCT02622659
Sponsor: Guangzhou Yipinhong Pharmaceutical CO.,LTD
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Upper Respiratory Infection

Start date: 2012-03-01
Primary completion: 2014-03-01
Enrollment: 468

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.